Sep 1, 2026 07:02AM
Sep 1, 2026 07:01AM
Aug 18, 2026 06:42AM
Aug 13, 2026 04:05PM
Aug 4, 2026 07:01AM
Jul 8, 2026 06:43AM
Jul 6, 2026 07:06AM FDA notifies Invivyd that Pemgarda EUA will end June 2027
Jul 6, 2026 07:01AM
Jul 2, 2026 07:01AM
Jun 29, 2026 07:00AM
Jun 16, 2026 07:01AM
Jun 16, 2026 07:01AM
Jun 9, 2026 07:01AM
Jun 9, 2026 07:01AM Invivyd Announces First Participants Dosed in LIBERTY, a Phase 3 Clinical Trial to Evaluate the Safety and Tolerability of VYD2311 Antibody Versus mRNA COVID Vaccine and to Characterize the Safe
Jun 3, 2026 07:01AM
Jun 1, 2026 07:02AM
Jun 1, 2026 07:01AM
May 27, 2026 07:01AM
May 14, 2026 07:01AM
May 11, 2026 07:01AM
May 11, 2026 07:01AM Invivyd and Collaborators Author New Manuscript Evaluating Early Tolerability of COVID Monoclonal Antibody and Comparing Results to COVID Vaccination
May 7, 2026 07:01AM
May 5, 2026 07:01AM
Apr 20, 2026 07:01AM
Apr 9, 2026 07:03AM
Apr 9, 2026 07:01AM
Apr 6, 2026 07:01AM
Mar 30, 2026 04:05PM Invivyd Announces Presentation at the World Vaccine Congress Washington
Mar 5, 2026 07:03AM
Mar 5, 2026 07:01AM
Mar 5, 2026 07:01AM
Mar 2, 2026 04:10PM
Mar 2, 2026 04:01PM
Feb 24, 2026 07:01AM
Feb 4, 2026 07:09AM H.C. Wainwright Reiterates Buy Rating on Invivyd Inc. (IVVD)
Feb 3, 2026 07:01AM
Feb 3, 2026 07:01AM
Jan 22, 2026 07:01AM
Jan 22, 2026 07:01AM
Jan 20, 2026 07:01AM
Jan 20, 2026 07:01AM
Jan 8, 2026 07:08AM Invivyd reports $17.2 million Q4 revenue, up 25% year-over-year
Jan 8, 2026 07:01AM
Dec 23, 2025 07:05AM
Dec 23, 2025 07:05AM
Dec 23, 2025 07:01AM
Dec 23, 2025 07:01AM
Nov 25, 2025 07:01AM
Nov 24, 2025 07:01AM Invivyd identifies RSV antibody candidate VBY329 for pediatric prevention
Nov 24, 2025 07:01AM

330,123 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All